Page last updated: 2024-08-23

diaziquone and Benign Meningeal Neoplasms

diaziquone has been researched along with Benign Meningeal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balis, FM; Berg, SL; Doherty, K; Gillespie, A; Holcenberg, J; Murphy, RF; Reaman, G; Sato, J; Steinherz, P; Zimm, S1
Balis, FM; Blaney, SM; Poplack, DG1

Trials

1 trial(s) available for diaziquone and Benign Meningeal Neoplasms

ArticleYear
Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Spinal; Male; Meningeal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma

1992

Other Studies

1 other study(ies) available for diaziquone and Benign Meningeal Neoplasms

ArticleYear
Pharmacologic approaches to the treatment of meningeal malignancy.
    Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Blood-Brain Barrier; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Infant; Infant, Newborn; Leukemia; Meningeal Neoplasms; Mercaptopurine; Methotrexate; Thiotepa

1991